Sylvan Baca MD PhD (Hiring!)
@sylvanbacalab
GU oncologist and computational epigenomics enthusiast at @DanaFarber, Assistant Professor @harvardmed
ID: 1538558876043313152
https://bacalab.dana-farber.org/ 19-06-2022 16:26:42
104 Tweet
678 Followers
351 Following
Congratulations to @danafarber researchers Erin Parry, MD, PhD (Erin Parry, MD PhD), Lachelle Weeks, MD, PhD (Lachelle Dawn), and Megan Insco, MD, PhD, who were awarded the Damon Runyon Clinical Investigator Award. Read more ms.spr.ly/6013ll1QP
Huge congrats to Talal El Zarif, MD and Karl Semaan, MD, MSc and all team for this great and timely paper presenting a real-life data in this hot-topic! OncoAlert Toni Choueiri, MD Daniel Heng IMDC Francesco Massari Rana McKay, MD, FASCO Sumanta K. Pal, MD, FASCO Sylvan Baca MD PhD (Hiring!) Hedyeh Ebrahimi Tian Zhang, MD, MHS Marc Eid
Congratulations Eli Van Allen!
Understanding #KEYNOTE564: Pembrolizumab’s role and post-adjuvant therapy for #RCC patients. Karl Semaan, MD, MSc & Talal El Zarif, MD join Zach Klaassen in this discussion of the evolving landscape in RCC treatment. #WatchNow > bit.ly/4e1l9mN Dana-Farber
Determination of tumor PSMA expression in #ProstateCancer from blood using a novel epigenomic liquid biopsy platform. Presented by Praful Ravi Dana-Farber Lank Center for Genitourinary Oncology. #ESMO24 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3ZJ1Fjd ESMO - Eur. Oncology
🎉Congrats rising star 🌟🌟🌟 Karl Semaan, MD, MSc , MD and post-doc from Dana-Farber Lank Center for Genitourinary Oncology for his great poster at #ESMO24 🌟✨🌟 Emre Yekedüz Toni Choueiri, MD
Dr. Karl Semaan, MD, MSc is a physician-scientist trained Sylvan Baca MD PhD (Hiring!), #FreedmanLab Toni Choueiri, MD Labs for 2 years (Comp Bio), >20 original pubs, team player and... today The Lancet Oncology 1st author. IM programs should take note of this winner. IMG_stories IMG Oncologists
Thank you, Dana-Farber! I'm so grateful and excited to use this award to push the boundaries of epigenomic liquid biopsy to improve cancer care.
Join us! Our division (Dana-Farber Division of Population Sciences) Dana-Farber and Harvard Medical School is hiring at the assistant/associate prof level. Under the fantastic leadership of Eli Van Allen, this division has been such a supportive place to launch a career in cancer research.
Honored to be awarded best poster at the International Society of Liquid Biopsy #ISLB24 Annual Congress for our work using a novel epigenomic liquid biopsy platform to detect PSMA expression and predict Pluvicto response in mCRPC. CC: fantastic collaborators Praful Ravi Heather Jacene Precede Biosciences
Congrats Allison Fitzgerald, MD, PhD! Dana Farber is lucky to have you join!
Beautiful work on profiling prostate cancer epigenomes from plasma to reveal clinical subtypes: pubmed.ncbi.nlm.nih.gov/39652574/ Congratulations, @researchwyatt, David Takeda, and team! Still amazes me what a detailed view of gene regulation in cancer cfChIP-seq provides.
Thank you Dana-Farber Lank Center for Genitourinary Oncology! Congrats to Jeremiah Wala and Bill Lotter, and my deep gratitude to the Wong Family for helping us improve cancer care!
So proud of mentees Razane El Hajj Chehade, Karl Semaan, MD, MSc, Rashad Nawfal, MD, and Marc Eid for their fantastic talks at ASCO #GU25. Their translational projects should lead to better outcomes for patients with kidney or prostate cancer.
So excited for you, Karl Semaan, MD, MSc and thrilled you'll be staying in the neighborhood at Brigham and Women's Medicine Residents. It's a testament to the incredible hard work you've put in over the last two years in lab. Looking forward to collaborations to come!
Excited to share this molecular case report in npj Journals led by Karl Semaan, MD, MSc and Rashad Nawfal, MD. I expect to see more of this rare resistance mechanism with advances in AR-targeting therapy. Great colab with @Jberchuck, Toni Choueiri, MD, and #MattFreedman. nature.com/articles/s4169…
